Outcome | Follow-up (months) | Treatment effect | Heterogeneity | Publication bias | Number of studies | ||||
---|---|---|---|---|---|---|---|---|---|
 |  | Effect measure | Pooled estimate (95% CI) | Pvalue for treatment effect | Pvalue for Cochran's Q test | I squared statistica | Number of studies trimmedb | Adjusted pooled estimatec |  |
Functional status | 1 | Hedges' g | 0.11 (-0.22 to 0.45) | 0.50 | 0.009 | 79% | 0 | 0.11 (-0.22 to 0.45) | |
 | 3 |  | 0.07 (-0.11 to 0.26) | 0.44 | 0.006 | 73% | 0 | 0.07 (-0.11 to 0.26) | |
 | 6 |  | 0.09 (-0.14 to 0.33) | 0.41 | 0.034 | 63% | 1 | 0.15 (-0.07 to 0.37) | |
 | 12 |  | 0.01 (-0.15 to 0.16) | 0.94 | 0.15 | 44% | 0 | 0.01 (-0.15 to 0.16) | |
Length of stay | Â | Weighted mean difference | -0.35 (-1.24 to 0.55) | 0.45 | 0.75 | 0% | 1 | -0.34 (-1.24 to 0.56) | |
Mortality | 1 | Relative risk | 0.66 (0.40 to 1.09) | 0.10 | 0.46 | 0% | NA | NA | |
 | 3/4 |  | 0.72 (0.44 to 1.17) | 0.19 | 0.12 | 47% | 0 | 0.72 (0.44 to 1.17) | |
 | 6 |  | 0.66 (0.52 to 0.85) | 0.001 | 0.37 | 0% | 2 | 0.73 (0.52 to 1.02) | |
 | 8 |  | 0.51 (0.31 to 0.85) | 0.009 | 0.39 | 0% | NA | NA | |
 | 12 |  | 0.98 (0.86 to 1.11) | 0.75 | 0.52 | 0% | 2 | 1.01 (0.87 to 1.16) | |
Readmission | 1 | Relative risk | 0.65 (0.25 to 1.67) | 0.37 | 0.59 | 0% | NA | NA | |
 | 3 |  | 0.93 (0.82 to 1.04) | 0.18 | 0.74 | 0% | 2 | 0.94 (0.84 to 1.05) | |
 | 6 |  | 0.88 (0.40 to 1.96) | 0.76 | 0.001 | 86% | 0 | 0.88 (0.40 to 1.96) | |
 | 12 |  | 0.99 (0.83 to 1.19) | 0.94 | 0.34 | 12% | 2 | 1.09 (0.87 to 1.36) |